The role of NMR-based circulating metabolic biomarkers in development and risk prediction of new onset type 2 diabetes

[1]  Warren W. Kretzschmar,et al.  Genotyping and population structure of the China Kadoorie Biobank , 2022, medRxiv.

[2]  J. Emberson,et al.  Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study , 2021, BMC Medicine.

[3]  R. Clarke,et al.  Circulating metabolites and the development of type 2 diabetes in Chinese adults , 2021, Diabetes care.

[4]  Xu Lin,et al.  Associations of plasma glycerophospholipid profile with modifiable lifestyles and incident diabetes in middle-aged and older Chinese , 2021, Diabetologia.

[5]  Jennifer G. Robinson,et al.  n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies , 2021, Diabetes Care.

[6]  V. Salomaa,et al.  Metabolic biomarkers for peripheral artery disease compared with coronary artery disease: Lipoprotein and metabolite profiling of 31,657 individuals from five prospective cohorts , 2020, medRxiv.

[7]  Jennifer G. Robinson,et al.  Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies , 2020, PLoS medicine.

[8]  Yu Xu,et al.  High-Coverage Targeted Lipidomics Reveals Novel Serum Lipid Predictors and Lipid Pathway Dysregulation Antecedent to Type 2 Diabetes Onset in Normoglycemic Chinese Adults , 2019, Diabetes Care.

[9]  Jian-Min Yuan,et al.  Serum Amino Acids in Association with Prevalent and Incident Type 2 Diabetes in A Chinese Population , 2019, Metabolites.

[10]  T. Lehtimäki,et al.  Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts , 2019, bioRxiv.

[11]  Min-Jeong Shin,et al.  Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study , 2018, Scientific Reports.

[12]  E. Boerwinkle,et al.  Serum metabolomic profile of incident diabetes , 2018, Diabetologia.

[13]  R. Collins,et al.  Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke , 2018, Journal of the American College of Cardiology.

[14]  Olga V. Demler,et al.  Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women's Health Study. , 2017, Journal of clinical lipidology.

[15]  D. Cox,et al.  Large numbers of explanatory variables, a semi-descriptive analysis , 2017, Proceedings of the National Academy of Sciences.

[16]  Yichong Li,et al.  Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013 , 2017, JAMA.

[17]  Tero Aittokallio,et al.  Early metabolic markers identify potential targets for the prevention of type 2 diabetes , 2017, Diabetologia.

[18]  Debbie A Lawlor,et al.  Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies , 2017, American journal of epidemiology.

[19]  T. Hansen,et al.  Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels , 2017, Diabetologia.

[20]  Inês Barroso,et al.  Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis , 2016, PLoS medicine.

[21]  F. Hu,et al.  Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults. , 2016, International journal of epidemiology.

[22]  Jian-Min Yuan,et al.  Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS , 2016, Diabetologia.

[23]  L. Liang,et al.  Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study , 2016, Diabetes Care.

[24]  Jin Guo,et al.  Risk scores for predicting incidence of type 2 diabetes in the Chinese population: the Kailuan prospective study , 2016, Scientific Reports.

[25]  N. Paynter,et al.  Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial. , 2016, JAMA cardiology.

[26]  Frank B Hu,et al.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis , 2016, Diabetes Care.

[27]  Sophie V. Eastwood,et al.  Diabetes risk and amino acid profiles: cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall And Brent REvisited) Study , 2015, Diabetologia.

[28]  C. Matthews,et al.  Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults , 2015, Metabolomics.

[29]  Dean P. Jones,et al.  Novel Metabolic Markers for the Risk of Diabetes Development in American Indians , 2014, Diabetes Care.

[30]  M. Garg,et al.  Higher omega-3 index is associated with increased insulin sensitivity and more favourable metabolic profile in middle-aged overweight men , 2014, Scientific Reports.

[31]  R. Collins,et al.  Associations of blood glucose and prevalent diabetes with risk of cardiovascular disease in 500 000 adult Chinese: the China Kadoorie Biobank , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[32]  Jean Sanderson,et al.  Derivation and assessment of risk prediction models using case-cohort data , 2013, BMC Medical Research Methodology.

[33]  M. Laakso,et al.  Glycerol and Fatty Acids in Serum Predict the Development of Hyperglycemia and Type 2 Diabetes in Finnish Men , 2013, Diabetes Care.

[34]  A. Kong,et al.  Diabetes and its comorbidities—where East meets West , 2013, Nature Reviews Endocrinology.

[35]  Gabi Kastenmüller,et al.  Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance , 2013, Diabetes.

[36]  D. Chisholm,et al.  Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. , 2013, Endocrine reviews.

[37]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[38]  Karel G M Moons,et al.  Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study , 2012, BMJ : British Medical Journal.

[39]  R. Collins,et al.  China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. , 2011, International journal of epidemiology.

[40]  Trisha Greenhalgh,et al.  Risk models and scores for type 2 diabetes: systematic review , 2011, BMJ : British Medical Journal.

[41]  Reino Laatikainen,et al.  High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. , 2009, The Analyst.

[42]  Mika Kivimäki,et al.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study , 2009, The Lancet.

[43]  M. Faraj,et al.  Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome , 2007, Current opinion in lipidology.

[44]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[45]  A. Jenkins,et al.  Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. , 2003, Diabetes.

[46]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[47]  R. L. Prentice,et al.  A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .